article thumbnail

Are You Ready for a Hong Kong IPO?

JD Supra: Mergers

With deep and liquid capital markets offering unique access to the Mainland China investor market, many international businesses are considering pursuing their IPOs in Hong Kong. By: Skadden, Arps, Slate, Meagher & Flom LLP

IPO 183
article thumbnail

The 2025 IPO Market

JD Supra: Mergers

Are we headed for an IPO rebound in 2025? According to a recent CNBC article, a major window for the IPO market could be opening.

IPO 165
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2024 Technology and Life Sciences IPO Report

JD Supra: Mergers

Wilson Sonsini's 2024 Technology and Life Sciences IPO Report provides in-depth analysis on 33 initial public offerings (IPOs) completed by U.S.-based based technology and life sciences companies in 2024 with deal values exceeding $75 million. By: Wilson Sonsini Goodrich & Rosati

IPO 165
article thumbnail

SEC Adopts Final Rules Related to SPAC IPOs and DeSPAC Transactions

JD Supra: Mergers

1] The Final Rules are intended to provide enhanced protections for investors in the initial public offerings (IPOs) of SPACs and the subsequent business combination transactions of SPACs with private operating companies (“de-SPAC transactions”). By expanding the disclosure requirements for SPAC IPOs (on. By: Robinson & Cole LLP

IPO 183
article thumbnail

Monetizing Analytics Features: Why Data Visualizations Will Never Be Enough

Think your customers will pay more for data visualizations in your application? Five years ago they may have. But today, dashboards and visualizations have become table stakes. Discover which features will differentiate your application and maximize the ROI of your embedded analytics. Brought to you by Logi Analytics.

article thumbnail

Key Takeaways for Life Sciences Companies Considering a 2025 IPO

JD Supra: Mergers

The outlook for life sciences IPOs is showing renewed optimism heading into 2025, with market conditions becoming more constructive and regulatory environments potentially more favorable. By: Fenwick & West LLP

IPO 165
article thumbnail

Eyes on the exit: Selling PE portfolio companies in complex markets

JD Supra: Mergers

Sluggish M&A and IPO markets have put the brakes on private equity exit activity across Europe, but as pressure builds to clear the backlog of unsold portfolio companies, firms are taking innovative approaches to selling businesses - Europes private equity firms have a large backlog of unsold portfolio companies sitting on their books, and the (..)

Portfolio 171